This year, the Nobel Prize in medicine went to Victor Ambros, currently a Professor of Natural Science at the University of Massachusetts Medical School, and Gary Ruvkun, a Professor of Genetics at Harvard Medical School. The two men won the award for their discovery of microRNA. One of the key questions of science is figuring…
In mid-May, Mandi Rokx had a 3-month-old baby and a letter from a Florida agency warning that they both would be cut from Medicaid, the health insurance program for people with low incomes or disabilities. Under a Florida law passed in 2021, Rokx was supposed to receive 12 months of continuous coverage after giving birth….
Sounder Benefits, which was built at Redesign Health, launched last week with $7.5 million in funding. The company is a health tech startup specializing in benefits for employers with fewer than 1,000 employees. The post Sounder Benefits Launches To Advance Employee Health Benefits appeared first on MedCity News.
Other ideas that emerged from fall 2023 summit meeting were a task force on primary care and health equity and a state scorecard on primary care
A third health system has started using Cytovale’s early sepsis detection test. Froedtert & the Medical College of Wisconsin Health Network announced its plans to deploy the diagnostic test this week. The post Why Hospital EDs Are Adopting Cytovale’s Sepsis Test appeared first on MedCity News.
Cuando Pam McClure se enteró que el próximo año ahorraría casi $4,000 en sus medicamentos recetados dijo: “parece demasiado bueno para ser verdad”. Para finales de 2024, habrá gastado casi $6,000 en estos fármacos, incluido uno para controlar su diabetes. McClure, de 70 años, es una de las aproximadamente 3.2 millones de personas con un…
Results from the Phase 3 DREAMM-7 study show GSK drug Blenrep is helping multiple myeloma patients live longer compared to treatment with blockbuster Johnson & Johnson drug Darzalex. The data, presented Monday during the annual meeting of the American Society of Hematology, are part of a submission now under FDA review that could lead to…
At least according to CEOs from Novartis, Sanofi and AstraZeneca. Reuters reports: European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, the bloc would fall further behind the U.S., where tariff threats have triggered a wave of pharma investment announcements. AstraZeneca Chief Executive Officer Pascal Soriot said…
STONE MOUNTAIN, Ga. — As principal of Dunaire Elementary School, Sean Deas has seen firsthand the struggles faced by children living in extended-stay hotels. About 10% of students at his school, just east of Atlanta, live in one. The children, Deas said, often have been exposed to violence on hotel properties, exhibit aggression or anxiety…
By MIKE MAGEE After Trump crashed the markets, citizens worldwide are “feeling the pressure.” But in the spirit of calming us down, let’s consider a story of human cooperation and success from our past. It has been estimated that a medical student learns approximately 15,000 new words during the four years of training. One of…